![LNC THERAPEUTICS raises € 6,5 million and reinforces its R&D in the microbiota field](https://www.seventure.fr/wp-content/uploads/2016/11/4__104270789-1-322x211.jpg)
28 September 2017
LNC THERAPEUTICS raises € 6,5 million and reinforces its R&D in the microbiota field
Cardiometabolic research specialist announces Sandrine Claus appointment as Chief Scientific Officer to lead its microbiota-oriented ambitious strategy.